Company profile: Integrity Bio
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing services focused on biologics formulation and GMP fill-finish. Offers formulation, process development, clinical and commercial production; cGMP analytical testing (chromatography, mass spectrometry, NMR); batch release and stability testing; separation science; analytical method development/validation; consultative services. Specializes in hard-to-formulate liquid and lyophilized products.
Products and services
- Analytical Method Development and Validation: Engineers and validates analytical methods for small molecules and biologics, ensuring precision and quality per ICH/FDA-compliant guidelines
- Analytical Testing Services: Delivers end-to-end cGMP-grade analytics, including chromatography, mass spectrometry, NMR spectroscopy, and other techniques, for compound profiling and product attribute analysis
- Sterile Fill Finish Manufacturing: Produces formulation and process development, clinical-phase production, and commercial sterile manufacturing of biologics, including hard-to-formulate liquid and lyophilized presentations, via GMP-compliant fill-finish operations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Integrity Bio
Beryllium
HQ: United States
Website
- Description: Provider of specialized drug discovery contract research services, collaborating with leading pharmaceutical, innovative biotechnology, and academic partners based on its innovative drug discovery platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Beryllium company profile →
Phasex
HQ: United States
Website
- Description: Provider of supercritical CO2 extraction for natural products, primarily serving the natural products, biopharmaceuticals, and polymers market segments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phasex company profile →
Frontida BioPharm
HQ: United States
Website
- Description: Provider of contract development and manufacturing services for biopharmaceutical companies, supporting scale-up and commercial manufacture of immediate and controlled release oral solid dose products, with capabilities to manufacture Highly Potent Active Ingredient products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Frontida BioPharm company profile →
Aenova
HQ: United States
Website
- Description: Provider of pharmaceutical and healthcare services, including development, manufacturing and packaging of pharmaceuticals and dietary supplements across oral solids, semi-solids, liquids, sterile dosage forms, and soft gelatin and vegan soft capsules. Offers formulation, process and analytical development, stability studies, regulatory support, clinical trial management, animal health services, and biologics fill and finish for vials and prefilled syringes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aenova company profile →
CPH
HQ: Switzerland
Website
- Description: Provider of chemical manufacturing and paper and packaging products for the chemical industries, serving the chemistry, paper, and packaging sectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CPH company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Integrity Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Integrity Bio
2.2 - Growth funds investing in similar companies to Integrity Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Integrity Bio
4.2 - Public trading comparable groups for Integrity Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →